Hear case studies from Merck Serono, MHRA, Teva, Cinfa Biotech and more | Biosimilars and Biobetters

LONDON - Sept. 16, 2015 - PRLog -- SMi's 6th annual Biosimilars and Biobetters conference, taking place on 30th September - 1st October 2015 in London, will gather industry experts to discuss the latest issues in the field with technical case studies. The conference programme will detail the latest regulatory updates and developments in the biosimilar commercial environment from Merck Serono, MHRA, Teva, Cinfa Biotech, Norwegian Medicines Agency and many more. Don’t miss out on this two-day conference which includes:
• 16 case studies + 2 in-depth workshops to drive commercial success
• 2 interactive panel discussions to learn from your industry colleagues
• 3 hours of valuable networking sessions
• Meeting biosimilars leaders outside of Europe

Featured Speakers include:
• Shahin Kauser, Senior Scientific Assessor, MHRA
• Chris Teale, Vice President Europe, GfK NOP Ltd
• Bracha Timan, Director, Israel Site Head, Global Bioassays & Technology, Global R&D, Teva
• Takashi Kei Kishimoto, Chief Scientific Officer, Selecta Biosciences
• Karsten Roth, Director Clinical Operations, Cinfa Biotech GmbH
• Alan Sheppard, Principal, Global Generics and Biosimilars, IMS Health
• Steinar Madsen, Medical Director, Norwegian Medicines Agency

To view the full speaker line-up and complete two-day conference programme, visit http://www.smi-online.co.uk/2015biosimilars1.asp

Plus, don't miss two interactive conference workshops:

Workshop A | 1:00pm - 5.30pm | 29th September 2015
Assessing the Regulatory Framework for Europe and the US – Developing Future Biologics
Workshop Leaders: Lincoln Tsung, Daniel Kracov, Jennifer Sklenar, Partners, Arnold & Porter (UK) LLP

Workshop B | 8:30am - 12.30pm | 2nd October 2015
Biosimilars - Understanding the Regulatory Processes and the Commercial Realities
Workshop Leader: Peter Wittner, Senior Consultant, Interpharm Consultancy